MELIS, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 194.279
NA - Nord America 8.243
AS - Asia 3.513
SA - Sud America 645
AF - Africa 107
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 9
Totale 206.842
Nazione #
IT - Italia 192.283
US - Stati Uniti d'America 8.065
SG - Singapore 1.387
CN - Cina 1.114
BR - Brasile 479
SE - Svezia 452
UA - Ucraina 450
VN - Vietnam 295
GB - Regno Unito 228
DE - Germania 219
FI - Finlandia 212
FR - Francia 190
HK - Hong Kong 122
IN - India 118
CA - Canada 109
BD - Bangladesh 77
KR - Corea 65
AR - Argentina 63
MX - Messico 42
NL - Olanda 41
IQ - Iraq 39
PH - Filippine 39
AU - Australia 38
TR - Turchia 32
ZA - Sudafrica 31
EC - Ecuador 26
AT - Austria 25
JP - Giappone 25
PL - Polonia 25
IL - Israele 23
PK - Pakistan 23
ID - Indonesia 21
IE - Irlanda 21
CO - Colombia 20
ES - Italia 20
BE - Belgio 19
MA - Marocco 19
MY - Malesia 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 17
VE - Venezuela 17
CL - Cile 16
IR - Iran 15
RU - Federazione Russa 15
UZ - Uzbekistan 11
KE - Kenya 10
EG - Egitto 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CR - Costa Rica 8
EU - Europa 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
AZ - Azerbaigian 7
GR - Grecia 7
HU - Ungheria 7
AL - Albania 6
BO - Bolivia 6
LK - Sri Lanka 6
LT - Lituania 6
NG - Nigeria 6
TH - Thailandia 6
ET - Etiopia 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
LV - Lettonia 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
PS - Palestinian Territory 3
SN - Senegal 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
HN - Honduras 2
MT - Malta 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DM - Dominica 1
GE - Georgia 1
GH - Ghana 1
Totale 206.826
Città #
Cagliari 188.459
Uta 3.375
Fairfield 894
Singapore 701
Ashburn 686
Woodbridge 628
San Jose 445
Houston 367
Chandler 339
Seattle 335
Dallas 328
Ann Arbor 320
Boardman 309
Wilmington 301
Cambridge 283
Nyköping 278
Jacksonville 233
Beijing 218
Dearborn 148
Helsinki 129
Los Angeles 126
The Dalles 125
Council Bluffs 119
Hong Kong 107
Ho Chi Minh City 100
Santa Clara 100
Lauterbourg 95
New York 91
Nanjing 81
Shanghai 78
Boston 77
Hefei 67
Hanoi 65
Buffalo 63
Seoul 59
San Diego 57
Guangzhou 46
Dong Ket 36
London 36
São Paulo 35
Nanchang 34
Milan 33
Munich 33
Toronto 33
Redwood City 32
Orem 31
Hebei 28
Shenyang 26
Atlanta 25
Frankfurt am Main 25
Tianjin 24
Chicago 23
Jiaxing 22
Rome 22
Dublin 21
Redondo Beach 21
Brooklyn 20
Norwalk 20
Changsha 19
Chennai 19
Mountain View 19
Phoenix 19
Johannesburg 18
Tokyo 17
Mexico City 16
Warsaw 16
Columbus 15
Mumbai 15
Brussels 14
Denver 14
Melbourne 14
San Francisco 14
Jinan 13
Vienna 13
Falls Church 12
Santiago 12
Zhengzhou 12
Baghdad 11
Buenos Aires 11
Curitiba 11
Dhaka 11
Guayaquil 11
Kunming 11
Montreal 11
Philadelphia 11
Quezon City 11
Tashkent 11
Washington 11
Augusta 10
Belo Horizonte 10
Manchester 10
Newark 10
Nuremberg 10
Orange 10
Porto Alegre 10
Pune 10
Brasília 9
Da Nang 9
Düsseldorf 9
Lappeenranta 9
Totale 201.340
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.768
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 5.435
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.636
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.179
Maternal immune activation disrupts dopamine system in the offspring 4.152
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 3.504
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.484
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.358
Editorial: Exploring gender and sex differences in behavioral dyscontrol: From drug addiction to impulse control disorders 3.226
Sex differences in addictive disorders 3.182
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.095
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 3.028
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 3.025
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.955
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.739
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.723
New vistas on cannabis use disorder 2.644
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 2.630
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.620
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.601
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G alpha(i/o) protein inhibitor 2.566
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.546
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission 2.463
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.459
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system 2.446
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.381
Sex differences in impulsive and compulsive behaviors: a focus on drug addiction 2.361
Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction 2.346
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.311
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.183
Rehabilitating the addicted brain with transcranial magnetic stimulation 2.110
Altered chloride homeostasis decreases the action potential threshold and increase hyperexcitability in hippocampal neurons 2.042
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 2.011
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.861
Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids 1.801
Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission 1.800
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.779
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.767
Optogenetic inhibition of chemically induced hypersynchronized bursting in mice 1.757
Endocannabinoids and lipid mediators in brain functions 1.735
null 1.722
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.664
Gender differences in the outcome of offspring prenatally exposed to drugs of abuse 1.621
Consequences of Perinatal Cannabis Exposure 1.562
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects 1.531
Exercise craving potentiates excitatory inputs to ventral tegmental area dopaminergic neurons 1.473
The endocannabinoid system and nondrug rewarding behaviours 1.458
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.450
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.425
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.397
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.367
Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure 1.203
Role of 2-arachidonoylglycerol-mediated plasticity at inhibitory synapses onto midbrain dopamine neurons in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 1.192
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.166
Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission 1.165
COR758, a negative allosteric modulator of GABAB receptors 1.145
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.132
The dopamine hypothesis of drug addiction: hypodopaminergic state 1.130
I CANNABINOIDI ATTIVANO I NEURONI DOPAMINERGICI DEL SISTEMA MESOLIMBICOCORTICALE 1.128
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.125
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.098
Endocannabinoids and the processing of value-related signals 1.086
Fatty acid ethanolamides pinpoint nicotinic receptors and modulate neuronal excitability through nuclear receptor PPARα 1.072
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.062
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.039
A role for midbrain 2-arachidonoylglycerol signalling in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 1.032
Choosing the right drug: status and future of endocannabinoid research for the prevention of drug-seeking reinstatement 1.001
Use of marijuana: effect on brain health and cognitive impairment 989
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 946
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 918
Endocannabinoids mediate pre-synaptic inhibition of glutamatergic transmission in rat VTA DA neurons through activation of CB1 receptors 863
null 850
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 842
null 841
From surface to nuclear receptors: the endocannabinoid family extends its assets 816
null 800
Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure 791
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 782
Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure 780
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 749
null 747
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 738
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 721
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 714
Presynaptic nanoscale components of retrograde synaptic signaling 691
Ethanol and acetaldehyde action on central dopamine systems: mechanisms,modulation and relation to stress 666
Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system 660
Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system 650
Different mechanism for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain 641
Electrophysiological effects of cannabinoids in the basal ganglia 586
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids 580
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 572
Sex-specific susceptibility to psychotic-like states provoked by prenatal THC exposure: Reversal by pregnenolone 567
COX- Inhibitors increase morphine effects on mesolimbic dopamine neurons 565
Clozapine potently stimulates mesocortical dopamine neurons 561
The cyclo-oxygenase inhibitor nimesulide induce conditioned place preference in rats 544
Clozapine does activate does activate nigrostriatal dopamine neurons in unanesthetized rats 541
Mesolimbic dopaminergic decline after cannabinoid withdrawal 536
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats 532
Totale 203.328
Categoria #
all - tutte 251.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 251.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.220 0 0 0 0 0 0 0 0 0 0 0 1.220
2021/202211.125 923 872 524 643 961 948 668 629 703 1.176 1.700 1.378
2022/202313.360 1.214 1.460 1.306 1.203 1.281 1.552 708 863 872 966 1.295 640
2023/202448.380 728 645 508 850 1.311 2.110 2.292 816 738 935 1.547 35.900
2024/202525.799 6.367 7.059 2.767 2.653 1.356 1.950 2.063 184 367 239 558 236
2025/20268.029 626 328 1.000 721 507 606 1.265 394 589 942 711 340
Totale 207.218